Current Landscape and Future Direction of PD-1/PD-L1 Checkpoint Inhibitors in Cancer Treatment.

Biomolecules

Department of Experimental and Clinical Biomedical Sciences, University of Florence, 50134 Florence, Italy.

Published: August 2023

Immune checkpoints are involved in controlling the activation or inhibition of the immune response and are associated with receptors on the immune cell surface [...].

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452670PMC
http://dx.doi.org/10.3390/biom13081209DOI Listing

Publication Analysis

Top Keywords

current landscape
4
landscape future
4
future direction
4
direction pd-1/pd-l1
4
pd-1/pd-l1 checkpoint
4
checkpoint inhibitors
4
inhibitors cancer
4
cancer treatment
4
treatment immune
4
immune checkpoints
4

Similar Publications

Background: As the pace of economic development slows, college students are facing an increasingly challenging employment landscape. For instance, the expansion of higher education has led to a swell in the number of job seekers, which has in turn intensified competition. Given the limited job opportunities, it's understandable that many college students are developing a pessimistic employment mindset.

View Article and Find Full Text PDF

In the current cybersecurity landscape, Distributed Denial of Service (DDoS) attacks have become a prevalent form of cybercrime. These attacks are relatively easy to execute but can cause significant disruption and damage to targeted systems and networks. Generally, attackers perform it to make reprisal but sometimes this issue can be authentic also.

View Article and Find Full Text PDF

Transforming Medicine: Cutting-Edge Applications of Nanoscale Materials in Drug Delivery.

ACS Nano

January 2025

CAS, a division of the American Chemical Society, Columbus, Ohio 43210, United States.

Since their inception in the early 1960s, the development and use of nanoscale materials have progressed tremendously, and their roles in diverse fields ranging from human health to energy and electronics are undeniable. The application of nanotechnology inventions has revolutionized many aspects of everyday life including various medical applications and specifically drug delivery systems, maximizing the therapeutic efficacy of the contained drugs by means of bioavailability enhancement or minimization of adverse effects. In this review, we utilize the CAS Content Collection, a vast repository of scientific information extracted from journal and patent publications, to analyze trends in nanoscience research relevant to drug delivery in an effort to provide a comprehensive and detailed picture of the use of nanotechnology in this field.

View Article and Find Full Text PDF

Purpose Of Review: To summarize the current treatment landscape of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) in the context of the recent 2023 American College of Rheumatology/American College of Chest Physicians guideline for ILD treatment in systemic autoimmune rheumatic diseases.

Recent Findings: The guideline conditionally recommends mycophenolate, azathioprine, and rituximab for first-line RA-ILD therapy, with cyclophosphamide and short-term glucocorticoids as additional options. For RA-ILD progression after first line, mycophenolate, rituximab, nintedanib, tocilizumab, cyclophosphamide, and pirfenidone are conditionally recommended, while long-term glucocorticoids are conditionally recommended against.

View Article and Find Full Text PDF

Conservationists are increasingly leveraging systematic conservation planning (SCP) to inform restoration actions that enhance biodiversity. However, restoration frequently drives ecological transformations at local scales, potentially resulting in trade-offs among wildlife species and communities. The Conservation Interactions Principle (CIP), coined more than 15 years ago, cautions SCP practitioners regarding the importance of jointly and fully evaluating conservation outcomes across the landscape over long timeframes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!